AMNEAL PHARMACEUTICALS ($AMRX) posted quarterly earnings results on Thursday, October 30th. The company reported earnings of $0.17 per share, beating estimates of $0.14 by $0.03. The company also reported revenue of $784,510,000, missing estimates of $787,756,200 by $-3,246,200.
You can see Quiver Quantitative's $AMRX stock page to track data on insider trading, hedge fund activity, congressional trading, and more.
AMNEAL PHARMACEUTICALS Insider Trading Activity
AMNEAL PHARMACEUTICALS insiders have traded $AMRX stock on the open market 15 times in the past 6 months. Of those trades, 0 have been purchases and 15 have been sales.
Here’s a breakdown of recent trading of $AMRX stock by insiders over the last 6 months:
- TASOS KONIDARIS (Executive Vice President & CFO) has made 0 purchases and 3 sales selling 499,730 shares for an estimated $4,663,070.
- ANDREW S BOYER (Executive Vice President) has made 0 purchases and 2 sales selling 312,680 shares for an estimated $2,921,904.
- NIKITA SHAH (Executive Vice President) has made 0 purchases and 4 sales selling 242,526 shares for an estimated $2,284,259.
- GAUTAM PATEL has made 0 purchases and 3 sales selling 103,574 shares for an estimated $830,490.
- JOHN KIELY has made 0 purchases and 2 sales selling 82,000 shares for an estimated $674,860.
- JASON B. DALY (EVP, Chief Legal Officer) sold 22,000 shares for an estimated $199,100
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
AMNEAL PHARMACEUTICALS Hedge Fund Activity
We have seen 139 institutional investors add shares of AMNEAL PHARMACEUTICALS stock to their portfolio, and 90 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- MILLENNIUM MANAGEMENT LLC added 2,955,629 shares (+141.6%) to their portfolio in Q2 2025, for an estimated $23,911,038
- CITADEL ADVISORS LLC removed 1,867,347 shares (-24.9%) from their portfolio in Q2 2025, for an estimated $15,106,837
- VANGUARD GROUP INC added 1,788,664 shares (+11.3%) to their portfolio in Q2 2025, for an estimated $14,470,291
- ROYAL BANK OF CANADA added 1,528,625 shares (+15261.8%) to their portfolio in Q2 2025, for an estimated $12,366,576
- WOODLINE PARTNERS LP removed 1,504,095 shares (-100.0%) from their portfolio in Q2 2025, for an estimated $12,168,128
- HENNESSY ADVISORS INC removed 1,499,400 shares (-100.0%) from their portfolio in Q2 2025, for an estimated $12,130,146
- ASSENAGON ASSET MANAGEMENT S.A. added 1,401,190 shares (+187.1%) to their portfolio in Q3 2025, for an estimated $14,025,911
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.
